The Deep Tech Decade: Cantos Chats Where Deep Tech is Headed in 2022

The Deep Tech Decade: Cantos Chats Where Deep Tech is Headed in 2022
Near Frontier
The Deep Tech Decade: Cantos Chats Where Deep Tech is Headed in 2022
/
Episode 3 February 09, 2022 00:29:53

Hosted By

Ian Rountree Amee Kapadia Andrew Kirima

Show Notes

Cantos analysts Amee and Andrew dive into their top predictions for what deep tech might see in 2022. 

Shownotes:

  1. Our 2022 predictions blog post
  2. Trailblazer's List by Mina Fahmi: https://trailblazerlist.xyz/
  3. Loonshots by Safi Bahcall
  4. Speed & Scale by John Doerr
  5. New funding models in biotech
  6. Nuclear energy blog post

Other Episodes

May 23, 2022

Building Space Planes with Sassie Duggleby of Venus Aerospace

Today we're joined by Sassie Duggleby, co-founder and CEO of Venus Aerospace. Venus is a Houston-based aerospace company building hypersonic space planes that fly at Mach 9 taking you anywhere in the world within an hour. We talk about hypersonics, challenges in building airframes that can support hypersonic speeds, and how Sassie has built an inclusive and balanced culture at Venus. If you're curious about the future of transportation, then this episode is for you.  Twitter: Venus Aerospace, Sassie Duggleby Website: Venus Aerospace ...

Play

00:59:43

February 22, 2022

Synthetic Biology and Biomanufacturing with Joshua Britton from Debut Biotech

Today we're joined by Dr. Joshua Britton, founder and CEO of Debut Biotech, a cell-free biomanufacturing company. Josh gives us a crash course on synthetic biology and biomanufacturing, walking us through the various methods and promise of this industry that may very well shift industrial production away from fossil fuels. We also get into some of the founding story of Debut, including how Cantos' investment in Debut came to be...hint: it had to do with a cold message.  Shownotes: Power: Limits and Prospects foor Human Survial by Richard Heinberg McKinsey report on synthetic biology Debut Biotech on Twitter ...

Play

00:56:28

August 24, 2022

The Fourth Pillar of Cancer w/ Anand Parikh of Faeth Therapeutics

Today we're joined by Anand Parikh, founder and CEO of Faeth Therapeutics. Faeth combines precision nutrition, therapeutics, and digital health to deliver a cancer-fighting program designed to deprive tumors of the nutrients they need to grow while providing optimal nutritional support to healthy tissues.  In this episode, we get into what led Anand to start Faeth, dig into the operational complexity behind the business's software, therapeutics, and nutrition aspects, discuss fundraising for an unconventional business model, and more.  Get in touch— Anand's socials Enroll in Faeth's clinical trials here Check out Faeth's open roles here   ...

Play

00:59:58